Yelin Lapidot Holdings Management Ltd. Compugen LTD Transaction History
Yelin Lapidot Holdings Management Ltd.
- $567 Billion
- Q2 2024
A detailed history of Yelin Lapidot Holdings Management Ltd. transactions in Compugen LTD stock. As of the latest transaction made, Yelin Lapidot Holdings Management Ltd. holds 318,852 shares of CGEN stock, worth $583,499. This represents 0.09% of its overall portfolio holdings.
Number of Shares
318,852
Previous 318,852
-0.0%
Holding current value
$583,499
Previous $823 Million
34.88%
% of portfolio
0.09%
Previous 0.17%
Shares
1 transactions
Others Institutions Holding CGEN
# of Institutions
75Shares Held
13.4MCall Options Held
191KPut Options Held
135K-
Silverarc Capital Management, LLC1.5MShares$2.75 Million0.72% of portfolio
-
Taylor Frigon Capital Management LLC1.31MShares$2.41 Million1.06% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.29MShares$2.36 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.09MShares$1.99 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C31.02MShares$1.87 Million0.0% of portfolio
About COMPUGEN LTD
- Ticker CGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,624,600
- Market Cap $159M
- Description
- Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...